Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Credit

<ul><li>McKesson is one of the leading U.S. healthcare distributors and operates in an oligopolistic market along with rivals, Cardinal Health and AmerisourceBergen.</li><li>The company has continued its efforts towards improving its competitive edge in cancer and biopharma services through internal investment and acquisition.</li><li>The Medical-Surgical business has achieved market-leading positions in the primary and extended care markets through years of deliberate investment and expansion.</li></ul>

McKesson is one of the leading U.S. healthcare distributors and operates in an oligopolistic market along with rivals, Cardinal Health and AmerisourceBergen.The company has continued its efforts towards improving its competitive edge in cancer and biopharma services through internal investment and acquisition.The Medical-Surgical business has achieved market-leading positions in the primary and extended care markets through years of deliberate investment and expansion.

McKesson Corporation: Initiation of Coverage – Business Strategy & Recent Developments

Equity Bottom-Up

<ul><li>This is our first report on leading U.S. healthcare distributor, McKesson.</li><li>The company delivered a mixed quarterly result with revenues of $70.2 billion falling short of the Wall Street consensus.</li><li>McKesson is also extending its services to additional channels like the government, consumer, and direct-to-home sectors in response to the requirements of the patients.</li></ul>

This is our first report on leading U.S. healthcare distributor, McKesson.The company delivered a mixed quarterly result with revenues of $70.2 billion falling short of the Wall Street consensus.McKesson is also extending its services to additional channels like the government, consumer, and direct-to-home sectors in response to the requirements of the patients.

United States

McKesson Corporation distributes pharmaceuticals, medical-surgical supplies, and health and beauty care products throughout North America. The Company also develops, implements, and supports software that facilitates the integration of data throughout the health enterprise.  In addition, McKesson offers analytic, care management, and patient solutions for payers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Mckesson Corp (MCK US)

McKesson Corporation: Initiation of Coverage – Business Strategy & Recent Developments

McKesson is one of the leading U.S. healthcare distributors and operates in an oligopolistic market along with rivals, Cardinal Health and...

Baptista Research

McKesson Corporation: Initiation of Coverage – Business Strategy & Recent Developments

This is our first report on leading U.S. healthcare distributor, McKesson. The company delivered a mixed quarterly result with revenues of $70.2...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)